Erectile dysfunction cures and treatments are a hot marketing item, but an appeals court has forbidden POM Wonderful from advertising the supposed benefits of its products as something to cure ED, along with prostate cancer and heart disease.
>> See the natural ED Treatment video here:
The POM legal issue started in 2010 with the Federal Trade Commission issuing a complaint saying the POM claims were false and unsubstantiated. Renal & Urology News report that the study undertaken on prostate cancer was not blinded or controlled and the erectile dysfunction benefits were no more than a placebo.
“Today’s decision by the D.C. Circuit is a victory for consumers,” said FTC chairwoman Edith Ramirez, according to a press release. “It is in keeping with established law that advertisers who market products for serious health conditions must have rigorous science to back up those claims. The court specifically recognized that this applies to food and dietary supplement marketers such as POM. It also held that requiring a randomized, well-controlled human clinical study for future disease benefit claims is an appropriate remedy based on POM’s conduct.”
Requiring a randomized, controlled human clinical trial that proves benefit is certainly a step in the right direction.
Pomegranate juice maker POM Wonderful cannot advertise that its pomegranate drinks treat or prevent heart disease or other ailments unless it has proof, a U.S. appeals court said Friday, upholding an order by the Federal Trade Commission.
The U.S. Court of Appeals for the D.C. Circuit largely upheld a 2010 order by the Federal Trade Commission, which found that POM Wonderful’s advertising was misleading in claiming its products would treat or reduce the risk of diseases ranging from heart disease to prostate cancer to erectile dysfunction treatment.